[Is there any leeway for assessment beyond randomised clinical trials?]

Abstract

Randomised controlled trials provide the basis for assessing treatment efficacy. Yet decisions concerning the introduction of new medications and treatment regimens will have to consider more aspects than the ones that are usually assessed in trials. Here, two examples will be discussed to explain the options that health care systems provide.